<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00749723</url>
  </required_header>
  <id_info>
    <org_study_id>EUDRACT 2005-002618-40</org_study_id>
    <secondary_id>BfArM-4030755</secondary_id>
    <secondary_id>EC-105/05</secondary_id>
    <secondary_id>DKS 2006.01, DK 2008.17</secondary_id>
    <nct_id>NCT00749723</nct_id>
  </id_info>
  <brief_title>Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children</brief_title>
  <acronym>HIT-REZ-2005</acronym>
  <official_title>Therapy-Optimization Trial and Phase II Study for the Treatment of Relapsed or Refractory of Primitive Neuroectodermal Brain Tumors and Ependymomas in Children and Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bonn</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bonn</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve overall survival while maintaining a good quality of
      life in pediatric patients with refractory or recurrent brain tumors (medulloblastomas,
      supratentorial PNETs, ependymomas WHO grade II and III). Response to different chemotherapy
      options (intravenous versus oral chemotherapy, intraventricular chemotherapy) as part of a
      multimodal therapy will be assessed. Progression-free, overall survival and toxicity will be
      evaluated additionally.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parts of the study:

      P-HIT-REZ-2005: a trial for the treatment of relapsed PNETs (medulloblastomas,supratentorial
      PNETs)

      E-HIT-REZ-2005: a trial for the treatment of relapsed ependymomas (Phase II-Study with
      temozolomide)

      Phase II-Study: intraventricular therapy with etoposide in neoplastic meningitis in relapsed
      PNETs and ependymomas with subarachnoid tumor manifestation (window study)
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>February 2006</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>P-HIT-REZ 2005 study: two Chemotherapy-arms: progression-free survival from therapy start and response evaluation after the fourth therapy course</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>E-HIT-REZ 2005 study (Phase II Study &quot;Oral chemotherapy with temozolomide&quot;): Evaluation of response rate to the 60-days oral chemotherapy with temozolomide</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Phase II study &quot;Intraventricular therapy with etoposide&quot;: Evaluation of response rate to the 5-week intraventricular therapy with etoposide</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>P-HIT-REZ 2005 study: two Chemotherapy-arms: overall survival from start of therapy</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-HIT-REZ 2005 study: Chemotherapy-arm: progression-free survival from start of therapy</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-HIT-REZ 2005 study: Chemotherapy-arm: overall survival from start of therapy</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E-HIT-REZ 2005 study: Chemotherapy-arm: toxicity rate (CTC)</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phase II study &quot;Intraventricular therapy with etoposide&quot;: toxicity rate (CTC)</measure>
    <time_frame>8 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>P-HIT-REZ 2005 study: two Chemotherapy-arms: toxicity rate (CTC) in both arms</measure>
    <time_frame>8 years</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Recurrent Brain Tumors</condition>
  <condition>Supratentorial PNETs</condition>
  <condition>Medulloblastomas</condition>
  <condition>Ependymomas</condition>
  <arm_group>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intravenous chemotherapy with carboplatin/etoposide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: P-HIT-REZ 2005</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral chemotherapy with temozolomide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3: E-HIT-REZ 2005</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phase II</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intravent. Etoposide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phase II</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>carboplatin</intervention_name>
    <description>200 mg/m²/d continuously IV on day 1-4 of each 21-28-day-cycle. Number of cycles: until disease progression, maximum 4 cycles</description>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoposide</intervention_name>
    <description>100mg/m²/d continuously IV on day 1-4 of each 21-28 day cycle. Number of cycles: until disease progression, maximum 4 cycles</description>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>temozolomide</intervention_name>
    <description>150mg/m²/d p.o. on day 1-5 of a 21-28-day-cycle. Number of cycles: until progression or maximum up to 2 years</description>
    <arm_group_label>2: P-HIT-REZ 2005</arm_group_label>
    <arm_group_label>3: E-HIT-REZ 2005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>thiotepa, carboplatin, etoposide</intervention_name>
    <description>HD-chemotherapy prior to stem cell transplantation</description>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>temozolomide, thiotepa</intervention_name>
    <description>HD-chemotherapy prior to autologous stem cell transplantation</description>
    <arm_group_label>2: P-HIT-REZ 2005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous stem cell transplantation</intervention_name>
    <description>autologous stem cell transplantation following HD-chemotherapy</description>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
    <arm_group_label>2: P-HIT-REZ 2005</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoposide</intervention_name>
    <description>prior to systemic chemotherapy as single agent in patients with neoplastic meningitis, in addition to systemic chemotherapy if proven effective in phase II study, intraventricularly age-dependent daily dose (&gt;3m to &lt;3y 0.7 mg; &gt;3y 1.0 mg) for 5 days every 2 two 4 weeks. Number of cycles: at least 3 courses, maximum up to 2 years</description>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
    <arm_group_label>2: P-HIT-REZ 2005</arm_group_label>
    <arm_group_label>3: E-HIT-REZ 2005</arm_group_label>
    <arm_group_label>Intravent. Etoposide</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>trofosfamide/etoposide</intervention_name>
    <description>maintenance therapy: trofosfamide/etoposide: 25 and 100 mg/m²/d for 21 days every 4 weeks. Number of cycles: until progression or maximum up to 2 years</description>
    <arm_group_label>1: P-HIT-REZ 2005</arm_group_label>
    <arm_group_label>3: E-HIT-REZ 2005</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Disease Characteristics

          -  Histologically confirmed Medulloblastoma, cerebral PNET or Ependymoma

          -  Refractory or relapsed disease

          -  Measurable disease by MRI or detection of tumor cells in cerebrospinal fluid Patients
             characteristics

          -  Performance status ECOG ≥ 3 or Karnofsky Status ≥ 40%

          -  Life expectancy ≥ 8 weeks

        Hematological:

          -  Absolute leukocyte count ≥ 2.0 x 10^9 /l

          -  Hemoglobin ≥ 10g/dl

          -  Platelet count ≥ 70 x 10^9/l

        Renal:

          -  Creatinine no greater than 1.5 times UNL

          -  No overt renal disease

        Hepatic:

          -  Bilirubin less than 2.5 times UNL

          -  AST and ALT less than 5 times UNL

          -  No overt hepatic disease

        Pulmonary:

          -  No overt pulmonary disease

        Cardiovascular:

          -  No overt cardiovascular disease

        Other:

          -  Not pregnant or nursing

          -  Negative pregnancy test

          -  Fertile patients must use effective contraception

          -  No uncontrolled infection Prior concurrent therapy

          -  More than 2 weeks since prior systemic chemotherapy

          -  More than 4 weeks since prior radiotherapy

          -  No other concurrent anticancer or experimental drugs Examinations required

          -  Examination of lumbar CSF

          -  Cranial and spinal MRI within 14 days prior to start of treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gudrun Fleischhack, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatric Hematology &amp; Oncology, Pediatrics III, University Children's Hospital Essen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätskinderklinik Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Berlin-Buch, Klinik für Kinderheilkunde und Jugendmedizin</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Klinikum Campus Virchow, Kinderklinik</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik ür Kinder- und Jugendmedizin in Bethel</name>
      <address>
        <city>Bielefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53113</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Braunschweig, Kinderklinik</name>
      <address>
        <city>Braunschweig</city>
        <zip>38118</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen-Mitte</name>
      <address>
        <city>Bremen</city>
        <zip>28177</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carl-Thiele-Klinikum Cottbus, Zentrum für Kinderheilkunde</name>
      <address>
        <city>Cottbus</city>
        <zip>03048</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vestische Kinder- und Jugendklinik Datteln</name>
      <address>
        <city>Datteln</city>
        <zip>45711</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dortmund, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Dresden, Kinderklinik</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Duisburg, Klinik für Kinder-und Jugendmedizin</name>
      <address>
        <city>Duisburg</city>
        <zip>47055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Erfurt, Zentrum für Kinderheilkunde</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Essen</name>
      <address>
        <city>Essen</city>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Wolfgang Goethe Universität, Klinik für Kinderheilkunde</name>
      <address>
        <city>Frankfurt/Main</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg, Zentrum für Kinderheilkunde</name>
      <address>
        <city>Gießen</city>
        <zip>35385</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Martin-Luther-Universität Halle Wittenberg</name>
      <address>
        <city>Halle/Saale</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule, Zentrum für Kinderheilkunde</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SLK Kinderklinik Heilbronn</name>
      <address>
        <city>Heilbronn</city>
        <zip>74078</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftskrankenhaus Herdecke, Kinderklinik</name>
      <address>
        <city>Herdecke</city>
        <zip>58313</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik</name>
      <address>
        <city>Homburg/Saar</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Friedrich Schiller Universität, Klinik für Kinder-und Jugendmedizin</name>
      <address>
        <city>Jena</city>
        <zip>07745</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Krankenhaus, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel, Kinderklinik</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UKSH, Campus Kiel, Klinik für Allg. Pädiatrie</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Kemperhof, Klinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Koblenz</city>
        <zip>56073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Köln</name>
      <address>
        <city>Köln</city>
        <zip>50924</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04317</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Lübeck</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Otto-von-Guericke-Universität, Zentrum für Kinderheilkunde</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Marburg</name>
      <address>
        <city>Marburg</city>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Minden III, Klinik für Kinder-und Jugendheilkunde</name>
      <address>
        <city>Minden</city>
        <zip>32432</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. von Haunersches Kinderspital</name>
      <address>
        <city>München</city>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Krankenhaus München-Schwabing, Kinderklinik der TU München</name>
      <address>
        <city>München</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Münster</name>
      <address>
        <city>Münster</city>
        <zip>48129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cnopf'sche Kinderklinik</name>
      <address>
        <city>Nürnberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg, Zentrum für Kinder-und Jugendmedizin</name>
      <address>
        <city>Oldenburg</city>
        <zip>26131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäts-Kinderklinik</name>
      <address>
        <city>Regensburg</city>
        <zip>93042</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Augustin GmbH</name>
      <address>
        <city>St. Augustin</city>
        <zip>53757</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Olgahospital-Pädiatrisches Zentrum</name>
      <address>
        <city>Stuttgart</city>
        <zip>70176</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univeritätsklinikum Ulm, Abteilung Kinder-und Jugendmedizin</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskinderklinik Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.kinderkrebsinfo.de/</url>
    <description>German Society of Pediatric Hematology and Oncology</description>
  </link>
  <link>
    <url>http://www.kinderkrebsstiftung.de/</url>
    <description>German Children's Cancer Foundation</description>
  </link>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2008</study_first_submitted>
  <study_first_submitted_qc>September 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2008</study_first_posted>
  <last_update_submitted>July 7, 2015</last_update_submitted>
  <last_update_submitted_qc>July 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Gudrun Fleischhack</investigator_full_name>
    <investigator_title>MD, Department of Pediatric Hematology &amp; Oncology, Pediatrics III, University Children's Hospital Essen</investigator_title>
  </responsible_party>
  <keyword>brain tumor</keyword>
  <keyword>relapse</keyword>
  <keyword>children</keyword>
  <keyword>etoposide</keyword>
  <keyword>intraventricular</keyword>
  <keyword>temozolomide</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Neoplasms</mesh_term>
    <mesh_term>Ependymoma</mesh_term>
    <mesh_term>Medulloblastoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temozolomide</mesh_term>
    <mesh_term>Etoposide phosphate</mesh_term>
    <mesh_term>Trofosfamide</mesh_term>
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Dacarbazine</mesh_term>
    <mesh_term>Etoposide</mesh_term>
    <mesh_term>Thiotepa</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

